Last reviewed · How we verify

Center for Research and Production of Vaccines and Biologicals, Vietnam — Portfolio Competitive Intelligence Brief

Center for Research and Production of Vaccines and Biologicals, Vietnam pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
ROTAVIN (liquid formulation) ROTAVIN (liquid formulation) phase 3 Live attenuated vaccine Immunology / Infectious Disease

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Bandim Health Project · 1 shared drug class
  2. Beijing Center for Disease Control and Prevention · 1 shared drug class
  3. Bharat Biotech International Limited · 1 shared drug class
  4. Canadian Immunization Research Network · 1 shared drug class
  5. Centers for Disease Control and Prevention · 1 shared drug class
  6. Changchun BCHT Biotechnology Co. · 1 shared drug class
  7. Changchun Keygen Biological Products Co., Ltd. · 1 shared drug class
  8. Aga Khan University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Center for Research and Production of Vaccines and Biologicals, Vietnam:

Cite this brief

Drug Landscape (2026). Center for Research and Production of Vaccines and Biologicals, Vietnam — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/center-for-research-and-production-of-vaccines-and-biologicals-vietnam. Accessed 2026-05-17.

Related